Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
R. Lejoyeux, E. Diwo, H. Vallet, D. Saadoun, S. Tezenas du Montcel, B. Bodaghi, P. LeHoang & C. Fardeau. (2018) INFLIXIMAB and ADALIMUMAB in Uveitic Macular Edema. Ocular Immunology and Inflammation 26:7, pages 991-996.
Read now
Read now
Audrey-Elodie Mercier, Emmanuel Ribeiro, Jean-François Korobelnik, Marie-Noëlle Delyfer & Marie-Bénédicte Rougier. (2018) Efficacy of Anti-TNF-α Therapy for the Treatment of Non-infectious Uveitis: A Retrospective Study of 21 Patients. Ocular Immunology and Inflammation 26:3, pages 477-484.
Read now
Read now
Miguel Cordero-Coma, Taygan Yilmaz & Sumru Onal. (2013) Systematic Review of Anti-Tumor Necrosis Factor-alpha Therapy for Treatment of Immune-mediated Uveitis. Ocular Immunology and Inflammation 21:1, pages 19-27.
Read now
Read now
Houman D Hemmati & James P Dunn. (2010) Biologic therapy for uveitis. Expert Review of Ophthalmology 5:2, pages 225-239.
Read now
Read now
Articles from other publishers (22)
Inês Leal, Laura R. Steeples, Shiao Wei Wong, Chiara Giuffrè, Sasa Pockar, Vinod Sharma, Elspeth K.Y. Green, Janine Payne, Nicholas P. Jones, Alice Sieu Eng Chieng & Jane Ashworth. (2024) Update on the systemic management of noninfectious uveitis in children and adolescents. Survey of Ophthalmology 69:1, pages 103-121.
Crossref
Crossref
Alejandro Gómez-Gómez, Alfredo Madrid-Garcia, Lara Borrego-Sanz, Paula Álvarez-Hernández, Pedro Arriola-Villalobos, Inés Pérez-Sancristobal, José M. Benítez del Castillo, Rosalía Mendez-Fernandez, Esperanza Pato-Cour, David Díaz-Valle & Luis Rodriguez-Rodriguez. (2022) Therapeutic Response After Immunosuppressive Drug Prescription in Non-infectious Uveitis: A Survival Analysis. Ophthalmology and Therapy 12:1, pages 139-153.
Crossref
Crossref
Amod Gupta. 2022. Biomedical Translational Research. Biomedical Translational Research
67
124
.
Jurgen Sota, Matteo-Maria Girolamo, Bruno Frediani, Gian Marco Tosi, Luca Cantarini & Claudia Fabiani. (2021) Biologic Therapies and Small Molecules for the Management of Non-Infectious Scleritis: A Narrative Review. Ophthalmology and Therapy 10:4, pages 777-813.
Crossref
Crossref
Sicong Li, Fang Liu, Kai Zhang, Yujia Tong & Xin Liu. (2021) Research Progress on the Mechanism of Natural Product Ingredients in the Treatment of Uveitis. Journal of Immunology Research 2021, pages 1-15.
Crossref
Crossref
Noy Ashkenazy, Ujwala S. Saboo, Ashley Abraham, Cristiana Ronconi & Jennifer H. Cao. (2019) Successful treatment with infliximab after adalimumab failure in pediatric noninfectious uveitis. Journal of American Association for Pediatric Ophthalmology and Strabismus 23:3, pages 151.e1-151.e5.
Crossref
Crossref
Ashvini Reddy, Fauziyya Muhammad & Darren J. Lee. 2019. Advances in the Diagnosis and Management of Uveitis. Advances in the Diagnosis and Management of Uveitis.
Glenda Espinosa-Barberi, Miguel Ángel Reyes Rodríguez & Félix Francisco Hernández. (2019) Enfermedad de Vogt-Koyanagi-Harada: estudio de 14 casos. Medicina Clínica 152:4, pages 159-160.
Crossref
Crossref
Glenda Espinosa-Barberi, Miguel Ángel Reyes Rodríguez & Félix Francisco Hernández. (2019) Vogt-Koyanagi-Harada disease: Study of 14 cases. Medicina Clínica (English Edition) 152:4, pages 159-160.
Crossref
Crossref
John A. Gonzales & Nisha Acharya. 2019. Posterior Uveitis. Posterior Uveitis
175
207
.
Claudia Fabiani, Jurgen Sota, Donato Rigante, Antonio Vitale, Giacomo Emmi, Giuseppe Lopalco, Lorenzo Vannozzi, Silvana Guerriero, Alice Bitossi, Ida Orlando, Rossella Franceschini, Bruno Frediani, Mauro Galeazzi, Florenzo Iannone, Gian Marco Tosi & Luca Cantarini. (2018) Efficacy of adalimumab and infliximab in recalcitrant retinal vasculitis inadequately responsive to other immunomodulatory therapies. Clinical Rheumatology 37:10, pages 2805-2809.
Crossref
Crossref
Lola E. Lawuyi & Avinash Gurbaxani. (2016) Refractory necrotizing scleritis successfully treated with adalimumab. Journal of Ophthalmic Inflammation and Infection 6:1.
Crossref
Crossref
Lana M. Rifkin, Andrea D. Birnbaum & Debra A. Goldstein. (2013) TNF Inhibition for Ophthalmic Indications: Current Status and Outlook. BioDrugs 27:4, pages 347-357.
Crossref
Crossref
Daniel Sánchez-Cano, José Luis Callejas-Rubio, Ricardo Ruiz-Villaverde, Raquel Ríos-Fernández & Norberto Ortego-Centeno. (2013) Off-Label Uses of Anti-TNF Therapy in Three Frequent Disorders: Behçet’s Disease, Sarcoidosis, and Noninfectious Uveitis. Mediators of Inflammation 2013, pages 1-10.
Crossref
Crossref
Mohsen FarvardinMehrdad AfaridSahab Shahrzad. (2012) Long-Term Effects of Intravitreal Infliximab for Treatment of Sight-Threatening Chronic Noninfectious Uveitis. Journal of Ocular Pharmacology and Therapeutics 28:6, pages 628-631.
Crossref
Crossref
Anne Riveros Frutos, Pau Romera Romero, Susana Holgado Pérez, José Ramón Anglada Escalona, Melania Martínez-Morillo & Beatriz Tejera Segura. (2012) Enfermedad de Vogt-Koyanagi-Harada. Seminarios de la Fundación Española de Reumatología 13:4, pages 142-146.
Crossref
Crossref
María Eugenia Mantrana-Bermejo & José Bernabeu-Wittel. (2012) Uveítis. Un reto diagnóstico multidisciplinar. Medicina Clínica 138:7, pages 293-295.
Crossref
Crossref
. 2012. Klinische Immunologie. Klinische Immunologie
e1
e80
.
Marc D. de Smet, Simon R.J. Taylor, Bahram Bodaghi, Elisabetta Miserocchi, Philip I. Murray, Uwe Pleyer, Manfred Zierhut, Talin Barisani-Asenbauer, Phuc LeHoang & Sue Lightman. (2011) Understanding uveitis: The impact of research on visual outcomes. Progress in Retinal and Eye Research 30:6, pages 452-470.
Crossref
Crossref
Aikaterini Arida, Kalliopi Fragiadaki, Eirini Giavri & Petros P. Sfikakis. (2011) Anti-TNF Agents for Behçet's Disease: Analysis of Published Data on 369 Patients. Seminars in Arthritis and Rheumatism 41:1, pages 61-70.
Crossref
Crossref
Carlos Jaime Velásquez Franco, Patricia Monsalve, Gloria Isabel Salazar Martínez, Ana Rivera, Liliana Zuluaga, Claudia Durán, Francisco Vargas, Aura Ligia Zapata-Castellanos & Oscar Jaír-Felipe Díaz. (2011) Uveítis y terapia anti-TNF. Revista Colombiana de Reumatología 18:1, pages 42-54.
Crossref
Crossref
Huili LiMasahiko YonedaMasayuki TakeyamaIichiro SugitaHinako TsunekawaHiroshi YamadaDaisuke WatanabeTomoyuki MukaiMasahiro YamamuraMasayoshi IwakiMasahiro Zako. (2010) Effect of Infliximab on Tumor Necrosis Factor-Alpha-Induced Alterations in Retinal Microvascular Endothelial Cells and Retinal Pigment Epithelial Cells. Journal of Ocular Pharmacology and Therapeutics 26:6, pages 549-556.
Crossref
Crossref